Invitae Corp (NVTA)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SERVICES-MEDICAL LABORATORIES

1400 16TH STREET SAN FRANCISCO, CA 94103

Invitae Corp provides genetic testing and genetic network services in the United States.

Data as of 2020-10-17
Market Cap9.508 Billion Shares Outstanding178.347 Million Avg 30-day Volume2.967 Million
P/E Ratio Dividend Yield EPS-3.9
Price/Sales53.8 Price cash flow ratio Price free cash flow ratio-31.6
Book Value2.6 Price to Tangible Book140.96 Alpha0.03
Short Interest Ratio6.86 % Short Interest to Float16.1 R-squared0.163839
BETA2.02345 52-week High/Low54.49 / 7.415 Stddev0.214689
View SEC Filings from NVTA instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 4 25.0% 3 (0.2%) 2 (0.13%) 50.0%
Funds Holding: 220 174 26.44% 50 (3.26%) 35 (2.24%) 42.86%
13F shares: 129.84 Million 101.997 Million 27.3% 56.895 Million 38.511 Million 47.74%
% Ownership 98.5237 81.9257 20.26% 43.1727 30.9324 39.57%
New Positions: 71 35 102.86% 19 4 375.0%
Increased Positions 82 65 26.15% 20 16 25.0%
Closed Positions 21 47 -55.32% 5 19 -73.68%
Reduced Positions 46 54 -14.81% 7 14 -50.0%
Total Calls 3.045 Million 2.353 Million 29.39% 1.221 Million 740.4 Thousand 64.86%
Total Puts 2.248 Million 2.186 Million 2.82% 970.1 Thousand 690.5 Thousand 40.49%
PUT/CALL Ratio 0.74 0.93 -20.43% 0.79 0.93 -15.05%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NVTA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NVTA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

28.1 Thousand total shares from 11 transactions

Exercise Derivative Conversion (M)

6.6 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STUELAND KATHERINE CHIEF COMMERCIAL OFFICER

  • Officer
238,352 2020-10-13 16

NUSSBAUM ROBERT L CHIEF MEDICAL OFFICER

  • Officer
215,211 2020-10-09 9

MYERS JASON W.

  • Director
  • PRESIDENT, ONCOLOGY
1,039,227 2020-10-02 2

GEORGE SEAN E PRESIDENT & CEO

  • Officer
638,376 2020-09-10 6

BRIDA THOMAS GENERAL COUNSEL

  • Officer
212,252 2020-09-10 6

GUYER SHELLY D CHIEF FINANCIAL OFFICER

  • Officer
227,520 2020-09-10 7

WERNER ROBERT F. CHIEF ACCOUNTING OFFICER

  • Officer
30,334 2020-09-10 5

LOCKHART KIMBER D

  • Director
0 2020-09-10 2

KNIGHT KENNETH D. CHIEF OPERATING OFFICER

  • Officer
325,000 2020-08-04 2

AGUIAR ERIC

  • Director
0 2020-07-15 2

BENDEKGEY E LEE CHIEF OPERATING OFFICER

  • Officer
218,311 2020-07-13 6

CROUSE GEOFFREY

  • Director
0 2020-04-30 1

GORJANC CHRISTINE MARIE

  • Director
0 2020-04-30 1

NAYAK CHITRA

  • Director
0 2020-04-30 1

SCOTT RANDAL W EXECUTIVE CHAIRMAN

  • Officer
  • Director
3,450,669 2019-08-26 0

DUMOND PATTY SEE REMARKS

  • Officer
88,811 2019-02-27 0

BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS (GP) LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
8,399,411 2018-03-28 0

THOMAS, MCNERNEY & PARTNERS II L.P.

TMP ASSOCIATES II LP

TMP NOMINEE II, LLC

THOMAS, MCNERNEY & PARTNERS II, LLC

  • 10% Owner
No longer subject to file 2016-12-01 0

ALDERSON LISA CHIEF STRATEGY OFFICER

  • Officer
24,319 2016-02-29 0

AGUIAR ERIC

THOMAS, MCNERNEY & PARTNERS II L.P.

TMP ASSOCIATES II LP

TMP NOMINEE II, LLC

THOMAS, MCNERNEY & PARTNERS II, LLC

  • Director
  • 10% Owner
3,732,460 2015-02-18 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2015-02-18 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

STUELAND KATHERINE - Officer CHIEF COMMERCIAL OFFICER

2020-10-15 17:38:01 -0400 2020-10-13 S 1,000 $51.36 d 238,352 direct yes 2.8918 2.8918 2 0.0 1

NUSSBAUM ROBERT L - Officer CHIEF MEDICAL OFFICER

2020-10-13 18:18:11 -0400 2020-10-09 M 6,550 $9.90 a 215,211 direct -3.2468 -10.6331 0.0 1 -10.6331 6

NUSSBAUM ROBERT L - Officer CHIEF MEDICAL OFFICER

2020-10-13 18:18:11 -0400 2020-10-09 M 6,550 a 63,450 direct

MYERS JASON W. - Director PRESIDENT, ONCOLOGY

2020-10-05 20:43:27 -0400 2020-10-02 A 1,039,227 a 1,039,227 direct 5.4094 10.6925 12.208 4 0.0 1

MYERS JASON W. - Director PRESIDENT, ONCOLOGY

2020-10-05 20:43:27 -0400 2020-10-02 A 643,839 a 643,839 direct

MYERS JASON W. - Director PRESIDENT, ONCOLOGY

2020-10-05 20:43:27 -0400 2020-10-02 A 278,417 a 278,417 direct

STUELAND KATHERINE - Officer CHIEF COMMERCIAL OFFICER

2020-09-16 18:44:02 -0400 2020-09-15 S 1,000 $35.51 d 239,352 direct yes 2.3803 9.3166 10.3148 4 0.0 1

NUSSBAUM ROBERT L - Officer CHIEF MEDICAL OFFICER

2020-09-14 18:43:13 -0400 2020-09-10 S 11,497 $33.86 d 210,391 direct yes 2.7173 10.4845 10.4845 6 0.0 1

STUELAND KATHERINE - Officer CHIEF COMMERCIAL OFFICER

2020-09-14 18:44:15 -0400 2020-09-10 S 631 $33.87 d 240,352 direct 2.7173 10.4845 10.4845 6 0.0 1

WERNER ROBERT F. - Officer CHIEF ACCOUNTING OFFICER

2020-09-14 18:47:25 -0400 2020-09-10 S 246 $33.87 d 30,334 direct 2.7173 10.4845 10.4845 6 0.0 1

NUSSBAUM ROBERT L - Officer CHIEF MEDICAL OFFICER

2020-09-14 18:43:13 -0400 2020-09-10 S 9,391 $32.97 d 221,888 direct yes 2.7173 10.4845 10.4845 6 0.0 1

GUYER SHELLY D - Officer CHIEF FINANCIAL OFFICER

2020-09-14 18:45:44 -0400 2020-09-10 S 631 $33.87 d 227,520 direct 2.7173 10.4845 10.4845 6 0.0 1

BRIDA THOMAS - Officer GENERAL COUNSEL

2020-09-14 18:41:56 -0400 2020-09-10 S 633 $33.87 d 212,252 direct 2.7173 10.4845 10.4845 6 0.0 1

NUSSBAUM ROBERT L - Officer CHIEF MEDICAL OFFICER

2020-09-14 18:43:13 -0400 2020-09-10 S 1,730 $34.69 d 208,661 direct yes 2.7173 10.4845 10.4845 6 0.0 1

NUSSBAUM ROBERT L - Officer CHIEF MEDICAL OFFICER

2020-09-14 18:43:13 -0400 2020-09-10 S 557 $33.87 d 231,279 direct 2.7173 10.4845 10.4845 6 0.0 1

GEORGE SEAN E - Officer PRESIDENT & CEO

2020-09-14 18:46:38 -0400 2020-09-10 S 742 $33.87 d 638,376 direct 2.7173 10.4845 10.4845 6 0.0 1

LOCKHART KIMBER D - Director

2020-09-11 16:37:03 -0400 2020-09-10 A 18,000 a 18,000 direct

BRIDA THOMAS - Officer GENERAL COUNSEL

2020-09-04 20:14:44 -0400 2020-09-03 A 1,257 a 212,885 direct 7.4429 29.044 56.2686 76.348 24 0.0 1

GEORGE SEAN E - Officer PRESIDENT & CEO

2020-09-04 20:08:44 -0400 2020-09-03 A 1,475 a 639,118 direct 7.4429 29.044 56.2686 76.348 24 0.0 1

NUSSBAUM ROBERT L - Officer CHIEF MEDICAL OFFICER

2020-09-04 20:12:26 -0400 2020-09-03 A 1,106 a 231,836 direct 7.4429 29.044 56.2686 76.348 24 0.0 1

WERNER ROBERT F. - Officer CHIEF ACCOUNTING OFFICER

2020-09-04 20:10:01 -0400 2020-09-03 A 543 a 30,580 direct 7.4429 29.044 56.2686 76.348 24 0.0 1

STUELAND KATHERINE - Officer CHIEF COMMERCIAL OFFICER

2020-09-04 20:13:35 -0400 2020-09-03 A 1,253 a 240,983 direct 7.4429 29.044 56.2686 76.348 24 0.0 1

GUYER SHELLY D - Officer CHIEF FINANCIAL OFFICER

2020-09-04 20:11:19 -0400 2020-09-03 A 1,253 a 228,151 direct 7.4429 29.044 56.2686 76.348 24 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments